BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9236819)

  • 1. Gender and ethnic differences in onchocercal skin disease in Oyo State, Nigeria.
    Brieger WR; Ososanya OO; Kale OO; Oshiname FO; Oke GA
    Trop Med Int Health; 1997 Jun; 2(6):529-34. PubMed ID: 9236819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-control relationship of onchocercal skin disease with onchocercal infection in Guinea Savanna, Northern Nigeria.
    Murdoch ME; Murdoch IE; Evans J; Yahaya H; Njepuome N; Cousens S; Jones BR; Abiose A
    PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005489. PubMed ID: 28355223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and parasitological aspects of onchocercal skin diseases in Nigeria.
    Dozie IN; Onwuliri CO; Nwoke BE; Onwuliri VA
    Trop Doct; 2005 Jul; 35(3):142-4. PubMed ID: 16105335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onchocerciasis: the clinical and epidemiological burden of skin disease in Africa.
    Murdoch ME; Asuzu MC; Hagan M; Makunde WH; Ngoumou P; Ogbuagu KF; Okello D; Ozoh G; Remme J
    Ann Trop Med Parasitol; 2002 Apr; 96(3):283-96. PubMed ID: 12061975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human onchocerciasis in Nigeria: isotypic responses and antigen recognition in individuals with defined cutaneous pathology.
    Murdoch ME; Abiose A; Garate T; Hay RJ; Jones BR; Maizels RM; Parkhouse RM
    Am J Trop Med Hyg; 1996 Jun; 54(6):600-12. PubMed ID: 8686779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The African Programme for Onchocerciasis Control: impact on onchocercal skin disease.
    Ozoh GA; Murdoch ME; Bissek AC; Hagan M; Ogbuagu K; Shamad M; Braide EI; Boussinesq M; Noma MM; Murdoch IE; Sékétéli A; Amazigo UV
    Trop Med Int Health; 2011 Jul; 16(7):875-83. PubMed ID: 21481109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of onchocerciasis and associated dermatologic and ophthalmic pathologies after 27 years of ivermectin mass drug administration in the middle belt of Ghana.
    Otabil KB; Basáñez MG; Ankrah B; Opoku SA; Kyei DO; Hagan R; Ababio R; Bart-Plange EJ; Babae TN; Kudzordzi PC; Darko VA; Bamfo JG; Ameyaw J; Raji AS; Hadermann A; Schallig HDFH; Colebunders R
    Trop Med Int Health; 2023 Nov; 28(11):844-854. PubMed ID: 37846505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of ivermectin on onchocercal skin disease and severe itching: results of a multicentre trial.
    Brieger WR; Awedoba AK; Eneanya CI; Hagan M; Ogbuagu KF; Okello DO; Ososanya OO; Ovuga EB; Noma M; Kale OO; Burnham GM; Remme JH
    Trop Med Int Health; 1998 Dec; 3(12):951-61. PubMed ID: 9892280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Babana Parasitic Diseases Project. I. The study area and a preliminary assessment of onchocercal endemicity based on the prevalence of "leopard skin".
    Edungbola LD; Oni GA; Aiyedun BA
    Trans R Soc Trop Med Hyg; 1983; 77(3):303-9. PubMed ID: 6623586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of health education on community participation in rapid assessment of onchocerciasis prior to distribution of ivermectin.
    Shu EN; Nwadike KI; Onwujekwe EO; Ugwu OC; Okonkwo PO
    East Afr Med J; 1999 Jun; 76(6):320-3. PubMed ID: 10750518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Field-Based Evidence of Single and Few Doses of Annual Ivermectin Treatment Efficacy in Eliminating Skin Microfilaria Load after a Decade of Intervention.
    Osue HO
    Ethiop J Health Sci; 2017 Mar; 27(2):129-138. PubMed ID: 28579708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermatological problems of onchocerciasis in Nebbi District, Uganda.
    Okello DO; Ovuga EB; Ogwal-Okeng JW
    East Afr Med J; 1995 May; 72(5):295-8. PubMed ID: 7555885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and parasitological aspects of itching caused by onchocerciasis in Morogoro, Tanzania.
    Makunde WH; Salum FM; Massaga JJ; Alilio MS
    Ann Trop Med Parasitol; 2000 Dec; 94(8):793-9. PubMed ID: 11214098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onchocerciasis in Anambra State, Southeast Nigeria: endemicity and clinical manifestations.
    Mbanefo EC; Eneanya CI; Nwaorgu OC; Otiji MO; Oguoma VM; Ogolo BA
    Postgrad Med J; 2010 Oct; 86(1020):578-83. PubMed ID: 20702432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of onchocerciasis in Ile-Ire District, (Ifelodun), Kwara State, Nigeria.
    Edungbola LD
    Trop Geogr Med; 1982; 34(3):231-9. PubMed ID: 7179463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of onchocerciasis in Nzerem-Ikpem, Nigeria: baseline prevalence and mass distribution of ivermectin.
    Abanobi OC; Anosike JC
    Public Health; 2000 Sep; 114(5):402-6. PubMed ID: 11035465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stigma associated with onchocercal skin disease among those affected near the Ofiki and Oyan Rivers in western Nigeria.
    Brieger WR; Oshiname FO; Ososanya OO
    Soc Sci Med; 1998 Oct; 47(7):841-52. PubMed ID: 9722105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethnic diversity and disease surveillance: Guinea worm among the Fulani in a predominantly Yoruba district of Nigeria.
    Brieger WR; Oke GA; Otusanya S; Adesope A; Tijanu J; Banjoko M
    Trop Med Int Health; 1997 Jan; 2(1):99-103. PubMed ID: 9018307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onchocerciasis in the Benue State of Nigeria. II. Prevalence of the disease among the Tivs living in the Kwande Local Government area.
    Gemade EI; Dipeolu OO
    Ann Trop Med Parasitol; 1983 Oct; 77(5):513-6. PubMed ID: 6660956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endemicity of onchocerciasis in some local government areas of Niger state.
    Idowu ET; Adewale B; Mafe MA; Appelt B; Bamgbose A
    Afr J Med Med Sci; 2004 Mar; 33(1):31-4. PubMed ID: 15490791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.